Lv1
26 积分 2023-12-27 加入
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
2天前
已完结
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial
8个月前
已关闭
Cancer mRNA vaccines: clinical advances and future opportunities
1年前
已完结
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading
1年前
已完结
皖公网安备34019202002308
